no statement of use filed
on 29 Mar 2021
Last Applicant/ Owned by
151 Oyster Point Blvd, Suite 400
South San Francisco
CA
94080
Serial Number
87421067 filed on 21st Apr 2017
Registration Number
N/A
Correspondent Address
Stephanie K. Wade
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
infections, inflammation; infections, inflammation; infections, inflammation; engineered cell therapies for medical purposes, namely, for use in treating cancer, infections, autoimmunity, and inflammation; infections, inflammation; assays and reagents for use in medical, medical diagnostic and therapeutic purposes for proteolytic activation and binding to tumor cells; biochemical test kits comprisRead More
Biochemicals for scientific, laboratory, and research use, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; diagnostic kits for scientific, laboratory, and research use comprising proteolytically-activatable or protease-activatable, proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells, and antigens; immunoglobulin and antigen-binding fragments for drug conjugation and targeted cell binding for laboratory and research use; assays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use
infections, inflammation; infections, inflammation; infections, inflammation; engineered cell therapies for medical purposes, namely, for use in treating cancer, infections, autoimmunity, and inflammation; infections, inflammation; assays and reagents for use in medical, medical diagnostic and therapeutic purposes for proteolytic activation and binding to tumor cells; biochemical test kits comprised of assays and reagents for medical, medical diagnostic and therapeutic purposes for proteolytic activation and binding to tumor cells; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery for medical, medical diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for use in identifying candidate patient populations for specific therapeutic treatments for medical purposes; therapeutic kits comprising proteolytically-activatable or protease-activatable, proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells, and antigens
Scientific research and development in the field of therapeutic biochemicals, engineered cell therapies and immunotherapy, oncology and dysregulated proteolytic activity; medical and scientific research and development for agents, preparations, products and technology in the field of dysregulated proteolytic activities; providing medical and scientific research information in the fields of biochemicals, engineered cell therapies, immunotherapy, oncology and dysregulated proteolytic activity; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating to biochemicals, engineered cell therapies and immunotherapy, proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services; online computer services in the nature of providing a search engine for obtaining data, namely, searching, retrieving, and providing information on antibodies and research topics pertaining to antibodies on a global computer network
No 87421067
No Service Mark
No S2986035
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 29th Mar 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 29th Mar 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 12th Aug 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 11th Aug 2020 | EXTENSION 5 GRANTED |
| 10th Aug 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 03rd Aug 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Jul 2020 | EXTENSION 5 FILED |
| 29th Jul 2020 | TEAS EXTENSION RECEIVED |
| 07th Feb 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 05th Feb 2020 | EXTENSION 4 GRANTED |
